Pesquisar
CareDx Inc
CDNAAdicionar à lista de desejos
19.970USD
-0.520-2.54%
Fechamento 05/15, 16:00（ET）Cotações atrasadas em 15 min
1.03BValor de mercado
PerdaP/L TTM
Mais detalhes de CareDx Inc Empresa
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.
Informações de CareDx Inc
Código da empresaCDNA
Nome da EmpresaCareDx Inc
Data de listagemJul 17, 2014
CEOHanna (John W)
Número de funcionários644
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 17
Endereço8000 Marina Blvd
CidadeBRISBANE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94005
Telefone14152872300
Sitehttps://www.caredx.com/
Código da empresaCDNA
Data de listagemJul 17, 2014
CEOHanna (John W)
Executivos da empresa CareDx Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
147.34K
+1.34%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
143.16K
-1.07%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
39.02K
-14.25%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
37.05K
-4.14%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
28.79K
-25.66%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
27.45K
--
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
8.17K
-867.03%
Mr. George W. Bickerstaff, III
Mr. George W. Bickerstaff, III
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
296.74K
-0.52%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
147.34K
+1.34%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
143.16K
-1.07%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
39.02K
-14.25%
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
37.05K
-4.14%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Testing Service revenue
274.50M
72.27%
Digital and other revenue
56.93M
14.99%
Product revenue
48.38M
12.74%
Por RegiãoUSD
Nome
Receita
Proporção
United States
359.94M
94.77%
Rest of the world
19.87M
5.23%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Testing Service revenue
274.50M
72.27%
Digital and other revenue
56.93M
14.99%
Product revenue
48.38M
12.74%
Distribuição de ações
Atualizado em: seg, 11 de mai
Atualizado em: seg, 11 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.79%
Baron Capital Management, Inc.
6.11%
State Street Investment Management (US)
5.30%
ARK Investment Management LLC
4.31%
Deerfield Management Company, L.P.
4.24%
Outro
72.25%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
7.79%
Baron Capital Management, Inc.
6.11%
State Street Investment Management (US)
5.30%
ARK Investment Management LLC
4.31%
Deerfield Management Company, L.P.
4.24%
Outro
72.25%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
43.81%
Investment Advisor
32.03%
Hedge Fund
20.15%
Research Firm
4.30%
Individual Investor
3.40%
Pension Fund
0.78%
Bank and Trust
0.42%
Insurance Company
0.03%
Family Office
0.02%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
469
52.46M
101.54%
-9.78M
2025Q4
443
52.64M
115.22%
+43.46K
2025Q3
457
52.61M
115.96%
-1.80M
2025Q2
454
53.72M
112.39%
-1.85M
2025Q1
443
55.89M
106.19%
-3.01M
2024Q4
439
52.97M
108.30%
+1.05M
2024Q3
434
51.58M
120.50%
-825.62K
2024Q2
407
52.51M
127.45%
-1.22M
2024Q1
435
53.86M
132.45%
-14.73M
2023Q4
448
52.78M
128.80%
-2.04M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
4.02M
7.85%
-97.03K
-2.36%
Dec 31, 2025
Baron Capital Management, Inc.
3.16M
6.16%
--
--
Dec 31, 2025
State Street Investment Management (US)
2.74M
5.35%
+171.30K
+6.67%
Dec 31, 2025
ARK Investment Management LLC
2.14M
4.17%
-34.22K
-1.58%
Dec 31, 2025
Deerfield Management Company, L.P.
2.19M
4.28%
--
--
Dec 31, 2025
Boston Partners
901.93K
1.76%
+870.57K
+2776.51%
Dec 31, 2025
Gagnon Securities LLC
1.77M
3.47%
+45.47K
+2.63%
Dec 31, 2025
Braidwell LP
1.59M
3.1%
-597.56K
-27.38%
Dec 31, 2025
Amova Asset Management Co., Ltd.
1.45M
2.82%
-293.45K
-16.86%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
ARK Genomic Revolution ETF
2.89%
ROBO Global Healthcare Technology & Innovation ETF
1.93%
Global X Genomics & Biotechnology ETF
0.87%
Franklin Genomic Advancements ETF
0.72%
State Street SPDR S&P Biotech ETF
0.34%
Direxion Daily S&P Biotech Bull 3X Shares
0.21%
iShares Micro-Cap ETF
0.16%
Fidelity Enhanced Small Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.11%
Principal U.S. Small-Cap ETF
0.1%
Ver Mais
ARK Genomic Revolution ETF
Proporção2.89%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.93%
Global X Genomics & Biotechnology ETF
Proporção0.87%
Franklin Genomic Advancements ETF
Proporção0.72%
State Street SPDR S&P Biotech ETF
Proporção0.34%
Direxion Daily S&P Biotech Bull 3X Shares
Proporção0.21%
iShares Micro-Cap ETF
Proporção0.16%
Fidelity Enhanced Small Cap ETF
Proporção0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.11%
Principal U.S. Small-Cap ETF
Proporção0.1%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
